Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
sharp increase » year increase (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
changes decrease » larger decrease (Expand Search), largest decrease (Expand Search), change increases (Expand Search)
sharp increase » year increase (Expand Search)
-
1161
Comparison of hardness ranges for different food categories under IDDSI levels.
Published 2025Subjects: -
1162
-
1163
Annual change in low-prevalence (orange) and hotspot (red) implementation units (IUs).
Published 2025Subjects: -
1164
-
1165
-
1166
-
1167
Table 1_Overexpression of TaPSKR1L-6A improves resistance to sharp eyespot and increases lignin accumulation in wheat.docx
Published 2025“…Overexpression of TaPSKR1L-6A significantly increased sheath blight resistance, upregulated the expression of lignin synthesis and metabolism pathway genes, and increased lignin accumulation, which was opposite to the results of silencing TaPSKR1L-6A. …”
-
1168
-
1169
-
1170
Changes in the white blood cell count.
Published 2025“…The leukocyte and neutrophil counts of the patients in the bone pain group were significantly higher than those of the patients in the no bone pain group, P(WBC) = 0.001, P(ANC) = 0.002.…”
-
1171
Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i>
Published 2025“…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …”
-
1172
-
1173
-
1174
-
1175
Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
1176
Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx
Published 2025“…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…”
-
1177
-
1178
-
1179
-
1180